Working in sarcoma research, personally transforming mission, and higher education with the light-hearted but whole-hearted spirit that Willie embodied.
Agenda and bios now posted!🚨 Oct 10, 2025: FDA & @OSInstitute workshop on advancing #osteosarcoma drug development. 🎯 Connecting research & regulatory pathways.
https://t.co/PLwPDgOvzK
#CancerResearch
So excited that years of work validating the prognostic value of ctDNA in pediatric sold tumors has led to this effort @BostonChildrens@DanaFarber and @broadinstitute to stand up a clinical liquid test specific for pediatric oncology. https://t.co/KOhsZhEK2i
We have two #postdoc positions open to join my team at @emblebi in Cambridge! We are a mission-driven, highly collaborative and dynamic team https://t.co/tKwOP7Lfa2 at the Wellcome Genome Campus, one of the most exciting hubs in the world focused on biomedical research 👇
It is always inspiring to see our young investigators and fellows at work @ctosociety. Thank you @AgentsMIB for partnering with us to bring past/present young investigators and osteosarcoma thought leaders together. It was a great week, and we look forward to next year!
The 2024-2025 Grant Cycle for the Osteosarcoma Institute is now open! If you are an osteosarcoma researcher or investigator, please visit our website to learn about our grant process and how to apply: https://t.co/zvb604GOrT.
Genevieve Kendall builds zebrafish models of rhabdomyosarcoma—the most common pediatric soft tissue sarcoma—to explore treatment strategies. A @quadwfoundation-AACR Fellowship supported her quest to help children with cancer:
https://t.co/swVcuForHz
#AACRGrants@KendallLabNCH
We love seeing our QuadW-AACR Fellows making an impact in their fields! That is what these grants are all about. Thank you for the shoutout @KendallLabNCH ! https://t.co/AkkUY5TqGV
Thrilled to participate in this year's #FACTOR#osteosarcoma conference - will present our recent work w Prof. Flanagan on the mechanisms underpinning osteo genome evolution https://t.co/KoEADlHkiT co-led by @je_valleinclan & Solange De Noon. Thanks @AgentsMIB for the invite!
Huge thanks to @ConquerCancerFd and @quadwfoundation for giving me this opportunity and for funding sarcoma research. Elated to join the growing network of QuadW researchers both near and far.
Great time attending #ASCO2024 and seeing past and present QuadW Young Investigator Awardees and Fellows making an impact in the #sarcoma field. Keep up the great work!
Thank you to the 785 donors who invested $3,088,245 for OSI research in 2023. Special thanks to the @quadwfoundation for covering our administrative costs, ensuring 100% of donations go directly to research. Help us to start 2024 strong by donating today! https://t.co/I9nN5PyHkC
The OSI is hiring a part-time, hybrid Administrative Assistant based in Dallas! Candidates must be Texas residents with three plus years of administrative experience and a keen eye for detail. View the full job description and instructions to apply at https://t.co/Z27g0AMDpd.
To close 2023, we present our work on #osteosarcoma genome and clonal evolution https://t.co/KoEADlGMtl How does #osteosarcoma arise? What rearrangement mechanisms cause some of the most complex #chromothripsis events seen in human cancer? Does chromothripsis occur subclonally?👇
The Osteosarcoma Institute recently held its inaugural meeting of the Board of Ambassadors. Dave Hartz (@dhartzm), Board Chair, lost his son Miles to osteosarcoma in June. Learn more about Dave’s inspiration for leading this exciting new fundraising board: https://t.co/IDhKe601FE
Congratulations and thank you @ctosociety for a fantastic meeting in Dublin! Loved watching our collaborators such as @janeway_MD give incredible talks that provide hope for the future.